Liquidmetal (LQMT) 10-K 6 Mar 18 2017 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2017	Mar. 02, 2018	Jun. 30, 2016
Document Information [Line Items]
Entity Registrant Name	LIQUIDMETAL TECHNOLOGIES INC
Entity Central Index Key	1,141,240
Trading Symbol	lqmt
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		908,776,866
Entity Public Float			$ 135,300,503
Document Type	10-K
Document Period End Date	Dec. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	FY
Amendment Flag	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Current assets:
Cash	$ 41,309	$ 58,896
Restricted cash	5	5
Trade accounts receivable, net of allowance for doubtful accounts	157	95
Inventory	391	390
Prepaid expenses and other current assets	326	312
Total current assets	42,188	59,698
Property and equipment, net	12,465	1,139
Patents and trademarks, net	408	494
Other assets	14	36
Total assets	55,075	61,367
Current liabilities:
Short-term debt	0	0
Accounts payable	92	331
Accrued liabilities	365	1,070
Deferred revenue	7	13
Total current liabilities	464	3,638
Long-term liabilities
Other long-term liabilities	856	856
Total liabilities	3,512	6,541
Shareholders' equity:
Preferred Stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2016 and December 31, 2015, respectively	0	0
Common stock, $0.001 par value; 1,100,000,000 shares authorized; 908,768,116 and 886,090,164 shares issued and outstanding at December 31, 2017 and December 31, 2016, respectively	909	886
Warrants	18,179	18,179
Additional paid-in capital	277,924	272,520
Accumulated deficit	(245,376)	(236,689)
Non-controlling interest in subsidiary	(73)	(70)
Total shareholders' equity	51,563	54,826
Total liabilities and shareholders' equity	55,075	61,367
Warrant [Member]
Current liabilities:
Derivative liabilities, current		2,224
Long-term liabilities
Warrant liabilities, long-term	2,192	2,047
Call Option [Member]
Current liabilities:
Derivative liabilities, current	$ 0	$ 0

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - $ / shares	Dec. 31, 2017	Dec. 31, 2016
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	1,100,000,000	1,100,000,000
Common stock, shares issued (in shares)	908,768,116	886,090,164
Common stock, shares outstanding (in shares)	908,768,116	886,090,164

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Revenue
Products	$ 255,000	$ 453,000	$ 98,000
Licensing and royalties	66,000	27,000	27,000
Total revenue	321,000	480,000	125,000
Cost of sales	696,000	553,000	349,000
Gross profit (loss)	(375,000)	(73,000)	(224,000)
Operating expenses
Selling, marketing, general and administrative	6,265,000	7,472,000	7,010,000
Research and development	1,962,000	2,342,000	2,047,000
Total operating expenses	8,227,000	9,814,000	9,057,000
Operating loss	(8,602,000)	(9,887,000)	(9,281,000)
Change in value of warrants, gain (loss)	(143,000)	(4,117,000)	1,946,000
Change in value of option liabilities, loss		(2,613,000)
Loss on contract modification		(2,126,000)
Interest expense		(9,000)	(4,000)
Interest income	55,000		22,000
Loss before income taxes	(8,690,000)	(18,752,000)	(7,317,000)
Income taxes
Net loss and comprehensive loss	(8,690,000)	(18,752,000)	(7,317,000)
Net loss attributable to non-controlling interest	3,000	8,000	8,000
Net loss and comprehensive loss attributable to Liquidmetal Technologies shareholders	$ (8,687,000)	$ (18,744,000)	$ (7,309,000)
Per common share basic and diluted:
Net loss per common share attributable to Liquidmetal Technologies shareholders, basic (in dollars per share)	$ (0.01)	$ (0.03)	$ (0.02)
Net loss per common share attributable to Liquidmetal Technologies shareholders, diluted (in dollars per share)	$ (0.01)	$ (0.03)	$ (0.02)
Number of weighted average shares - basic (in shares)	897,273,890	640,157,919	470,955,041
Number of weighted average shares - diluted (in shares)	897,273,890	640,157,919	470,955,041

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Preferred Stock [Member]	Common Stock [Member]	Warrant [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Noncontrolling Interest [Member]	Total
Balance (in shares) at Dec. 31, 2014		464,482,819
Balance at Dec. 31, 2014		$ 464	$ 18,179	$ 200,610	$ (210,636)	$ (54)	$ 8,563
Common stock issuance (in shares)		12,500,000
Common stock issuance		$ 13		1,555			1,568
Stock option exercises (in shares)		166,666
Stock option exercises				13			13
Stock-based compensation				1,375			1,375
Restricted stock issued to officer				182			182
Net loss					(7,309)	(8)	(7,317)
Balance (in shares) at Dec. 31, 2015		477,149,485
Balance at Dec. 31, 2015		$ 477	18,179	203,735	(217,945)	(62)	4,384
Common stock issuance (in shares)		405,000,000
Common stock issuance		$ 405		60,974			$ 61,379
Stock option exercises (in shares)		2,197,199					2,197,199
Stock option exercises		$ 2		204			$ 206
Stock-based compensation				1,694			1,694
Net loss					(18,744)	(8)	(18,752)
Written call options				3,124			3,124
Loss on contract modification				2,126			2,126
Warrant exercises (in shares)		1,743,480
Warrant exercises		$ 2		663			665
Balance (in shares) at Dec. 31, 2016		886,090,164
Balance at Dec. 31, 2016		$ 886	18,179	272,520	(236,689)	(70)	$ 54,826
Stock option exercises (in shares)		10,978,664					10,978,664
Stock option exercises		$ 11		1,227			$ 1,238
Stock-based compensation				1,255			1,255
Net loss					(8,687)	(3)	(8,690)
Warrant exercises (in shares)		11,699,288
Warrant exercises		$ 12		2,922			2,934
Balance (in shares) at Dec. 31, 2017		908,768,116
Balance at Dec. 31, 2017		$ 909	$ 18,179	$ 277,924	$ (245,376)	$ (73)	$ 51,563

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Operating activities:
Net loss	$ (8,690,000)	$ (18,752,000)	$ (7,317,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	634,000	527,000	522,000
Stock-based compensation	1,255,000	1,694,000	1,375,000
Loss on contract modification		2,126,000
Restricted stock compensation issued to officer			182,000
Loss (gain) from change in value of warrants	143,000	4,117,000	(1,946,000)
Loss from change in value of option liabilities		2,613,000
Changes in operating assets and liabilities:
Trade accounts receivable	(62,000)	(65,000)	53,000
Inventory	(1,000)	(307,000)	(83,000)
Prepaid expenses and other current assets	(14,000)	96,000	(34,000)
Other assets	22,000	(5,000)
Accounts payable and accrued liabilities	(944,000)	204,000	337,000
Deferred revenue	(6,000)	(64,000)	77,000
Net cash used in operating activities	(7,663,000)	(7,816,000)	(6,834,000)
Investing Activities:
Purchases of property and equipment	(11,874,000)	(198,000)	(675,000)
Decrease (increase) in restricted cash		2,003,000	(2,008,000)
Investment in patents and trademarks		(22,000)
Net cash provided by (used in) investing activities	(11,874,000)	1,783,000	(2,683,000)
Financing Activities:
Proceeds from (repayment of) short-term debt		(700,000)	700,000
Proceeds from exercise of stock options	1,238,000	206,000	13,000
Proceeds from exercise of warrants	712,000
Proceeds from stock issuance, net of issuance costs		62,650,000	1,568,000
Net cash provided by financing activities	1,950,000	62,156,000	2,281,000
Net increase (decrease) in cash	(17,587,000)	56,123,000	(7,236,000)
Cash at beginning of period	58,896,000	2,773,000	10,009,000
Cash at end of period	41,309,000	58,896,000	2,773,000
Supplemental Schedule of Non-Cash Financing Activities:
Cashless exercise of warrants	$ 2,222,000	$ 665,000

Note 1 - Description of Busines

Note 1 - Description of Business	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Business Description and Basis of Presentation [Text Block]	1 . Description of Business Liquidmetal Technologies, Inc. (the “Company”) is a materials technology and manufacturing company that develops and commercializes products made from amorphous alloys. The Company’s family of alloys consists of a variety of bulk alloys and composites that utilizes the advantages offered by amorphous alloys technology. The Company designs, develops, manufactures and sells products and custom parts from bulk amorphous alloys to customers in a wide range of industries. The Company also partners with third Amorphous alloys are , in general , unique materials that are distinguished by their ability to retain a random atomic structure when they solidify, in contrast to the crystalline atomic structure that forms in other metals and alloys when they solidify. Liquidmetal alloys are proprietary amorphous alloys that possess a combination of performance, processing, and potential cost advantages that the Company believes will make them preferable to other materials in a variety of applications. The amorphous atomic structure of bulk alloys enables them to overcome certain performance limitations caused by inherent weaknesses in crystalline atomic structures, thus facilitating performance and processing characteristics superior in many ways to those of their crystalline counterparts. The Company’s alloys and the molding technologies it employs results in components that exhibit: exceptional dimensional control and repeatability that rivals precision machining, excellent corrosion resistance, brilliant surface finish, high strength, high hardness, high elastic limit, alloys that are non-magnetic, and the ability to form complex shapes common to the injection molding of plastics. Interestingly, all of these characteristics are achievable from the molding process, so design engineers do not one not The Company ’s revenues are derived from i) selling bulk Liquidmetal alloy products to customers who produce medical devices, automotive assemblies, sports and leisure goods, and non-consumer electronic devices, ii) selling tooling and prototype parts such as demonstration parts and test samples for customers with products in development , iii) product licensing and royalty revenue, and iv) research and development revenue. The Company expects that these sources of revenue will continue to significantly change the character of the Company’s revenue mix.

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]	2 . Summary of Significant Accounting Policies Principles of Consolidation. The consolidated financial statements include the accounts of Liquidmetal Technologies, Inc., its special-purpose wholly-owned subsidiary, Crucible Intellectual Property, 20321 Non- C ontrolling I nterest. Revenue Recognition . Revenue is recognized pursuant to applicable accounting standards including FASB ASC Topic 605 605” 605 The Company ’s revenue recognition policy complies with the requirements of ASC 605. not not License revenue arrangements in general provide for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include the grant of an exclusive or non-exclusive right to manufacture and/or sell products covered by patented technologies owned or controlled by the Company. The intellectual property rights granted may Licensing revenues that are one upon the granting of the license are recognized when i) the license term begins in a manner consistent with the nature of the transaction and the earnings process is complete, ii) when collectability is reasonably assured or upon receipt of an upfront fee, and iii) when all other revenue recognition criteria have been met. Pursuant to the terms of these agreements, the Company has no Cash. The Company considers all highly liquid investments with maturity dates of three not December 31, 2017 2016, no Trade Accounts Receivable. The Company grants credit to its customers generally in the form of short-term trade accounts receivable. The creditworthiness of customers is evaluated prior to signing a contract with the customer. As of December 31, 2017, three 84%, $131, December 31, 2016, two 100%, $95, During 2017, five 63% 2016, three 73% 2015, three 52% may The allowance for doubtful accounts reflects management's best estimate of probable losses inherent in the trade accounts receivable. Management primarily determines the allowance based on the aging of accounts receivable balances, historical write-off experience, customer concentrations, customer creditworthiness and current industry and economic trends. The Company's provisions for uncollectible receivables are included in selling, marketing, general and administrative expense in the consolidated statements of operations and comprehensive loss. At December 31, 2017 2016, not Inventory. Inventory is stated at the lower of weighted-average cost or net realizable value. Inventory is recorded at actual cost when purchased and then expensed at weighted-average cost as used in production and/or shipped to satisfy customer orders. We perform an analysis of our inventory balances at least quarterly to determine if the carrying amount of inventories exceeds their net realizable value. The analysis of estimated net realizable value is based on customer orders, market trends and historical pricing. If the carrying amount exceeds the estimated net realizable value, the carrying amount is reduced to the estimated net realizable value. Property and Equipment. Property and equipment are stated at cost less accumulated depreciation and amortization. Additions and major renewals are capitalized. Repairs and maintenance are charged to expense as incurred. Upon disposal, the related cost and accumulated depreciation are removed from the accounts, with the resulting gain or loss included in operating income. Depreciation is provided principally on the straight-line method over the estimated useful lives of the assets, which range from one five Intangible A ssets. Intangible assets consist of the costs incurred to purchase patent rights and costs incurred to register and maintain patents and trademarks. Intangible assets are reported at cost, net of accumulated amortization. Patents and trademarks are amortized using the straight-line method over a period based on their contractual lives ranging from ten seventeen Impairment of Long-lived Assets . The Company reviews long-lived assets to be held and used in operations for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may may no December 31, 2017, 2016, 2015, Fair Value Measurements. The estimated fair values of financial instruments reported in the consolidated financial statements have been determined using available market information and valuation methodologies, as applicable. The fair value of cash and restricted cash approximate their carrying value due to their short maturities and are classified as Level 1 Fair value is defined as the exchange price that would be received for an asset o r paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Entities are required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value based upon the following fair value hierarchy: Level 1 — Quoted prices in active markets for identical assets or liabilities; Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not Level 3 — Unobservable inputs that are supported by little or no The Company has several financial instruments, namely warrant liabilities that are recorded at fair value on a periodic basis using Level 2 480 10, 815 25 1 815 10 15 74 11 12 As of December 31, 2017, Fair Value Level 1 Level 2 Level 3 Warrant liabilities (current) - - - - Warrant liabilities (long-term) 2,192 - 2,192 - As of December 31, 2016, Fair Value Level 1 Level 2 Level 3 Warrant liabilities (current) 2,224 - 2,224 - Warrant liabilities (long-term) 2,047 - 2,047 - Research and Development Expenses. Research and development expenses represent salaries, related benefits expense, expenses incurred for the design and testing of new processing methods and other expenses related to the research and development of Liquidmetal alloys. Development costs incurred in research and development activities are expensed as incurred. Advertising and Promotion Expenses. Advertising and promotion expenses are expensed when incurred. Advertising and promotion expenses were $154, $83 $76, December 31, 2017, 2016 2015, Legal Costs. Legal costs are expensed as incurred. Stock-Based Compensation . The Company accounts for share-based compensation in accordance with the fair value recognition provisions of FASB ASC Topic 718, Share-based Payment may Income Taxes. Income taxes are provided under the asset and liability method as required by FASB ASC Topic 740, Accounting for Income Taxes Under the provisions of FASB ASC Topic 740, no no no December 31, 2017, 2016 2015, Earnings Per Share. Basic earnings per share (“EPS”) is computed by dividing earnings (losses) attributable to common shareholders by the weighted average number of common shares outstanding for the periods. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates. These management estimates are primarily related to impairment of long-lived assets, allowance for bad debt, warrant valuations, and inventory valuation. Subsequent Events. The Company evaluated subsequent events through the filing of its Annual Report on Form 10 Supplemental Cash Flow Information. Cash payments for interest were $ 0, $9, $4 December 31, 2017, 2016, 2015, Recent Accounting Pronouncements. Leases In February 2016, December 15, 2018 not Revenue from Contracts with Customers In May 2014, for fiscal and interim periods beginning after December 15, 2017 not Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA and the SEC did not not

Note 3 - Significant Transactio

Note 3 - Significant Transactions	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Significant Transactions [Text Block]	3 . Significant Transactions Manufacturing Facility Purchase On February 16, 2017, he Company purchased a 41,000 July 2017. $7,818. 2016 On March 10, 2016, “2016 100% ’s Chairman and CEO, Professor Lugee Li (“Professor Li’). The 2016 405,000,000 $63,400. 105,000,000 $8,400 $0.08 March 10, 2016 200,000,000 $0.15 100,000,000 $0.25 $55,000 October 26, 2016. In addition to the shares issuable under the 2016 10,066,809 2,609,913 March 10, 2016 7,456,896 October 26, 2016 $0.07 tenth Further, the 2016 three ’s board of directors, with one 2016 fifth 2016 Eontec License Agreement On March 10, 2016, 2016 Ltd., a Hong Kong corporation (“Eontec”), entered into a Parallel License Agreement (the “License Agreement”) pursuant to which the Company and Eontec agreed to cross-license their respective technologies. The Company’s Chairman and CEO, Professor Li, is also a major shareholder and Chairman of Eontec. The License Agreement provides for the cross-license of certain patents, technical information, and trademarks between the Company and Eontec. In particular, the Company granted to Eontec a paid-up, royalty- free, perpetual license to the Company’s patents and related technical information to make, have made, use, offer to sell, sell, export and import products in certain geographic areas outside of North America and Europe. In turn, Eontec granted to the Company a paid-up, royalty-free, perpetual license to Eontec’s patents and related technical information to make, have made, use, offer to sell, sell, export and import products in certain geographic areas outside of specified countries in Asia. The license granted by the Company to Eontec is exclusive (including to the exclusion of the Company) in the countries of Brunei, Cambodia, China (P.R.C and R.O.C.), East Timor, Indonesia, Japan, Laos, Malaysia, Myanmar, Philippines, Singapore, South Korea, Thailand and Vietnam. The license granted by Eontec to the Company is exclusive (including to the exclusion of Eontec) in North America and Europe. The cross-licenses are non-exclusive in geographic areas outside of the foregoing exclusive territories. Beyond the License Agreement, the Company collaborates with Eontec to accelerate the commercialization of amorphous alloy technology. This includes but is not third During March 2017, h Eontec to purchase two $780. April 2017 fourth 2017 . 201 4 Purchase Agreement On August 20, 2014, “2014 $30,000 ’s common stock, $0.001 36 2014 On March 9, 2016, 2014 $1,568 2014 12,500,000 $0.13 Line of Credit Facility In February 2015, $2,000 2.1%, February 13, 2016. was extended through August 25, 2016, $1,000. August 26, 2016, $0 December 31, 2017, $9 December 31, 2016, $4 December 31, 2015. 2013 Agreement On November 8, 2013, entered into a Common Stock Purchase Agreement (the “2013 $20,000 36 2013 November 8, 2013, 2,666,667 On August 22, 2014, 2013 rchase Agreement, effective August 25, 2014. $16,000 2013 85,355,615 $0.19 July 2012 On July 2, 2012, “July 2012 $12,000 September 1, 2013. $0.352 8% twelve October 1, 2012. July 17, 2013, 163,641,547 14 As a part of the July 2012 18,750,000 $0.384 $0.17 11 Apple License Transaction On August 5, 2010, Company entered into a license transaction with Apple Inc. (“Apple”) pursuant to which (i) the Company contributed substantially all of its intellectual property assets to a newly organized special-purpose, wholly-owned subsidiary, called Crucible Intellectual Property, LLC (“CIP”), (ii) CIP granted to Apple a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in the field of consumer electronic products, as defined in the license agreement, in exchange for a license fee, and (iii) CIP granted back to the Company a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in all other fields of use. Under the agreements relating to the license transaction with Apple, the Company was obligated to contribute, to CIP, all intellectual property developed through February 2016. Visser Precision Cast, LLC License Agreement On June 1, 2012, Visser MTA”) with Visser Precision Cast, LLC (“Visser”) relating to a strategic transaction for manufacturing services and financing. On May 20, 2014, May 20, 2014 ( not not In addition, the settlement amended and restated the two June 2012 15,000,000 $0.22 21,317,094 $0.16 11 Other License Transactions On January 31, 2012, five (“Engel”) whereby Engel was granted a non-exclusive license to manufacture and sell injection molding machines to the Company’s licensees. Since that time, the Company and Engel have agreed on an injection molding machine configuration that can be commercially supplied and supported by Engel. On December 6, 2013, 10 The Company ’s Liquidmetal Golf subsidiary has the exclusive right and license to utilize the Company’s Liquidmetal alloy technology for purposes of golf equipment applications. This right and license is set forth in an intercompany license agreement between Liquidmetal Technologies and Liquidmetal Golf. This license agreement provides that Liquidmetal Golf has a perpetual and exclusive license to use Liquidmetal alloy technology for the purpose of manufacturing, marketing, and selling golf club parts and other products used in the sport of golf. The Company owns 79% In June 2003, LLPG”). Under the terms of the agreement, LLPG has the exclusive right to commercialize Liquidmetal alloys, particularly precious-metal based compositions, in jewelry and high-end luxury product markets. The Company, in turn, will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by LLPG. The exclusive license agreement with LLPG expires on December 31, 2021. In March 2009, Swatch”) under which Swatch was granted a non-exclusive license to the Company’s technology to produce and market watches and certain other luxury products. In March 2011,

Note 4 - Trade Accounts Receiva

Note 4 - Trade Accounts Receivable	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	4 . Trade accounts receivable Trade accounts receivable were comprised of the following: December 31, 2017 2016 Trade accounts receivable $ 157 $ 95 Less: Allowance for doubtful accounts - - Trade accounts receivable, net $ 157 $ 95

Note 5 - Prepaid Expenses and O

Note 5 - Prepaid Expenses and Other Current Assets	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Prepaid Expenses and Other Current Assets [Text Block]	5 . Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets totaled $326 $312 December 31, 2017 December 31, 2016, December 31, 2017 2016 Prepaid service invoices $ 116 $ 65 Prepaid manufacturing and mold costs - 27 Prepaid insurance premiums 210 220 Total 326 312

Note 6 - Inventory

Note 6 - Inventory	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Inventory Disclosure [Text Block]	6 . Inventory Inventory totaled $ 391 $390 December 31, 2017 December 31, 2016, December 31, 2017 2016 Raw materials $ 367 $ 350 Work in progress 24 25 Finished goods - 15 Total 391 390 During the fourth 2017, $279 2018. ’s technology and the overall view of prospective raw material prices to be used to fulfill future prototyping and production contracts. Given market entry challenges for a new technology, it has been determined that the material component of product pricing needs to be closer aligned with existing materials and technologies in order to be competitive. The Company expects that current research and development projects centered around reducing raw material costs, while maintaining quality and chemical specifications, will limit the impact of inventory price adjustments in future periods.

Note 7 - Property and Equipment

Note 7 - Property and Equipment	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	7 . Property and Equipment Property and equipment consist of the following: December 31, 2017 2016 Land, building, and improvements $ 8,947 $ - Machinery and equipment 5,577 $ 2,725 Computer equipment 253 236 Office equipment, furnishings, and improvements 181 564 Total 14,958 3,525 Accumulated depreciation (2,493 ) (2,386 ) Total property and equipment, net $ 12,465 $ 1,139 Depreciation expense for the years ended December 31, 2017, 2016 2015 $548, $429, $423, December 31, 2017, $42 $506 December 31, 2016, $20 $409 December 31, 2015, $29 $394 On February 16, 2017, 41,000 20321 92630. July 2017, or manufacturing and office space. The total purchase price for the property was $7,818, During March 2017, se two $780. April 2017 fourth 2017.

Note 8 - Patents and Trademarks

Note 8 - Patents and Trademarks, Net	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	8 . Patents and trademarks, net Patents and trademarks consist of the following: December 31, 2017 2016 Purchased and licensed patent rights $ 566 $ 566 Internally developed patents 1,686 1,686 Trademarks 148 148 Total 2,400 2,400 Accumulated amortization $ (1,992 ) $ (1,906 ) Total intangible assets, net $ 408 $ 494 Amortization expense was $86, $98, $99 December 31, 2017, 2016, 2015, five December 31, Aggregate Amortization Expense 2018 $ 86 2019 84 2020 81 2021 56 2022 29 Thereafter 72 Total $ 408 Accumulated amortization for the year s ended December 31, 2017 2016 December 31, 2017 2016 Purchased and licensed patent rights $ (541 ) $ (534 ) Internally developed patents (1,326 ) (1,253 ) Trademarks (125 ) (119 ) Total $ (1,992 ) $ (1,906 ) The weighted average amortization periods for the years ended December 31, 2017 2016 December 31, 2017 2016 Purchased and licensed patent rights 17 17 Internally developed patents 17 17 Trademarks 10 10 Purchased patent rights represent the exclusive right to commercialize the bulk amorphous alloy and other amorphous alloy technology acquired from California Institute of Technology (“Caltech”), through a license agreement with Caltech and other institutions. All fees and other amounts payable by the Company for these rights and licenses have been paid or accrued in full, and no In addition to the purchased and licensed patents, the Company has capitalized legal and registration costs incurred to obtain and maintain the respective patents. The Company currently holds various patents and numerous pending patent applications in the United States, as well as numerous foreign counterparts to these patents outside of the United States.

Note 9 - Short-term Debt

Note 9 - Short-term Debt	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Short-term Debt [Text Block]	9 . Short-Term Debt Short-term debt totaled $ 0 0 December 31, 2017 December 31, 2016, 2.1%. August 26, 2016. 0, $9, $4 December 31, 2017 , 2016, 2015, This credit facility require d the Company to maintain collateral for the full amount of the facility. Following maturity of the facility all collateral requirements have been removed.

Note 10 - Accrued Liabilities

Note 10 - Accrued Liabilities	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	1 0 . Accrued Liabilities Accrued liabilities totaled $ 365 $1,070 December 31, 2017 December 31, 2016, December 31, 2017 2016 Accrued payroll, vacation, and bonuses $ 149 $ 606 Accrued severance 164 301 Accrued audit fees 52 72 Straight-line rent accruals - 91 Total 365 1,070

Note 11 - Warrant Liabilities

Note 11 - Warrant Liabilities	12 Months Ended
	Dec. 31, 2017
Warrant [Member]
Notes to Financial Statements
Derivatives and Fair Value [Text Block]	1 1 . Warrant Liabilities Pursuant to FASB ASC 815, certain warrants as a liability at fair value and record the changes in the fair value of the warrant liabilities as a gain or loss in its consolidated statement of operations and comprehensive loss due to the price-based anti-dilution rights of warrants. During June 2012, e Company issued warrants to purchase a total of 15,000,000 $0.22 June 1, 2017 $4,260. 815. $0.16 March 22, 2017 December 31, 2016. 21,317,094 March 22, 2017 December 31, 2016. March 22, 2017 21,317,094 4,241,386 $975 $4 $971 December 31, 2017, 2016 2015 $553, $1,494 $1,019, On July 2, 2012, 18,750,000 as part of the July 2012 $0.384 January 2, 2018, $5,053. 815. 2013, 2014, 2016 , the exercise price of these warrants was reduced to $0.17 $0.17 December 31, 2017 December 31, 2016, . During the year ended December 31, 2017 July 2012 10,540,750 $0.17 7,457,902 $712, $1,247 December 31, 2017, 2016 2015 $551 $1,336 $927, On March 10, 2016, 10,066,809 2016 $0.07 March 10, 2026, $760. 815. December 31, 2017 , these warrants were valued at $2,192 8 .19 111%, 2.4%, 0. December 31, 2017, 2016, 2015 $145, $1,287, $0, The following table summarizes the change in the Company’s warrant liabilities for the year ended December 31, 2017: Visser MTA July 2, 2012 2016 Purchase Agreement Private Placement Agreement Total Ending Balance - December 31, 2016 $ 1,528 $ 696 $ 2,047 $ 4,271 Change in value of warrant liability, (gain) loss (553 ) 551 145 143 Exercises (975 ) (1,247 ) - (2,222 ) Ending Balance - December 31, 2017 $ - $ - $ 2,192 $ 2,192 Included in current liabilities $ - $ - $ - $ - Included in long-term liabilities $ - $ - $ 2,192 $ 2,192 The Company had warrants to purchase 10,066,809 41,924,653 December 31, 2017 December 31, 2016, 815. $143 , ( $4,117 $1,946 December 31, 2017, 2016, 2015, The fair value of warrants outstanding for the following periods was computed using the Black-Scholes model with the following range of assumptions: December 31, 2017 2016 Expected life in years 8.19 0.42 - 9.19 Volatility 111% 76% - 122% Risk-free interest rate 2.4% 0.6% - 2.5% Dividend rate 0% 0 As of December 31, 2017, Number of Shares Exercise Price Expiration Date 10,066,809 $ 0.07 March 10, 2026 10,066,809

Note 12 - Option Liabilities

Note 12 - Option Liabilities	12 Months Ended
	Dec. 31, 2017
Call Option [Member]
Notes to Financial Statements
Derivatives and Fair Value [Text Block]	1 2 . Option Liabilities As part of the 2016 granted the Investor the right to purchase shares of the Company’s common stock in the future at predetermined prices, of which the Investor was contractually obligated to effect following the satisfaction of certain conditions by the Company. These options allowed the Investor to purchase 200,000,000 $0.15 100,000,000 $0.25 815. 200,000,000 100,000,000 $489 $22, May 19, 2016 May 19, 2016, 200,000,000 100,000,000 $2,931 $193, 0.25 85%, 0.31%, 0. $0 $2,613 December 31, 2016. On August 11, 2016, amendment to the 2016 300,000,000 2016 August 17, 2016 December 31, 2016. not 2016 $2,126 December 31, 2016. October 26, 2016, 300,000,000

Note 13 - Other Long-term Liabi

Note 13 - Other Long-term Liabilities	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Other Liabilities Disclosure [Text Block]	1 3 . Other Long-Term Liabilities O ther Long-term Liabilities balance of $856 $856 December 31, 2017 2016, third 5

Note 14 - Shareholders' Equity

Note 14 - Shareholders' Equity	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	1 4 . S hare holders’ Equity Common stock In June 2012, 30,000,000 shares of common stock to Visse r in connection with the Visse r MTA (see note 3 Pursuant to the terms of the Company’s Senior Convertible Notes issued in the July 2012 twelve September 1, 2013 163,641,547 $0.0774, twelve $12,000 $680 (see note 3 During the year ended December 31, 2013, 506,936 16,896,070 no O n February 28, 2013, 400 500 O n October 24, 2013, 500 700 . In connection with the execution of the 2013 2,666,667 December 31, 2014, $16,000 2013 85,355,615 $0.19 August 22, 2014, 2013 August 25, 2014 ( 3 On September 9, 2014, 75,000,000 2014 September 30, 2015, $1,568 2014 12,500,000 $0.13 March 8, 2016, 2014 March 9, 2016 ( 3 In connection with the execution of the 2016 , on March 10, 2016, 105,000,000 $0.08 $8,400. On May 19, 2016, 700 1,100 On October 26, 2016, of the 2016 300,000,000 $55,000, 200,000,000 $0.15 100,000,000 $0.25 In 2012, a non-exclusive engagement agreement with an investment banking firm. The services provided by the firm did not 2013. 2016, not may November 2016, $750. December 31, 2016 Warrants In connection with the Series A Preferred Stock issuances in 2009, 29,779,557 $18,179, July 15, 2015. 2010, no not 815 $0.48 $0.49 July 15, 2015.

Note 15 - Stock Compensation Pl

Note 15 - Stock Compensation Plan	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	1 5 . Stock Compensation Plan On April 4, 2002, 2002 “2002 2002 10,000,000 may 2002 2002 April 2012, December 31, 2017, 189 ,000 2002 On June 28, 2012, 2012 ( “2012 , with the approval of the shareholders , which provided for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries. The 2012 422 1986, -statutory stock options. In addition, the Plan permits the granting of stock appreciation rights, or SARs, with or independently of options, as well as stock bonuses and rights to purchase restricted stock. A total of 30,000,000 may 2012 2017, 2,807,262 , with total options outstanding of 21,570,994 December 31, 2017 . On January 27, 2015, 2015 “2015 , which provided for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries . A total of 40,000,000 2015 . All options granted under the 2015 2017, 2,092,131 , with total options outstanding of 12,675,000 December 31, 2017 . FASB ASC 718, Compensation – Stock Compensation, 718, $1,255, $1,694, $1,557 December 31, 2017, 2016, 2015, not $1,665, $2,639, $3,904 December 31, 2017, 2016, 2015, On August 3, 2010, ’s former Chief Executive Officer, the Company also granted an aggregate of 6,000,000 five December 31, 2017, 2016, 2015, $0, $0, $182, The fair value of each option grant is estimated on the date of the grant using the Black-Scholes option-pricing model with the assumptions noted in the following table. December 31, 2017 2016 2015 Expected volatility 45.20% - 107.54% 56.48% - 115.39% 84.19% - 168.46% Expected dividends - - - Expected term (in years) .123 - 5.85 1.00 - 6.32 0.73 - 6.32 Risk-free rate 0.82% - 2.06% 0.76% - 2.13% 0.39% - 1.96% Expected volatilities are based on historical volatility expected over the expected life of the options. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The expected term of options grante d represents the period of time that options granted are expected to be outstanding. Forfeiture rates of 19.86%, 8.83% 5.34% December 31, 2017, 2016 2015, The following table summarizes the Company ’s stock option transactions for the years ended December 31, 2017 2016: Number of Shares Weighted Average Exercise Price Weighted Average Aggregate Intrinsic Value (in thousands) Options outstanding at December 31, 2015 41,910,734 0.21 Granted 23,064,401 0.10 Exercised (2,197,199 ) 0.09 Forfeited (12,931,033 ) 0.14 Expired (2,264,501 ) 0.19 Options outstanding at December 31, 2016 47,582,402 0.15 Granted 4,899,393 0.20 Exercised (10,978,664 ) 0.11 Forfeited (7,052,137 ) 0.15 Expired (16,000 ) 0.77 Options outstanding at December 31, 2017 34,434,994 $ 0.17 6.6 $ 2,685 Options exercisable at December 31, 2017 20,231,888 $ 0.17 5.7 $ 1,607 Options unvested at December 31, 2017 14,203,106 $ 0.17 8.0 $ 1,078 Options vested or expected to vest at December 31, 2017 32,763,190 $ 0.17 6.5 $ 2,564 The following table provides supplemental data on stock options for the years ended December 31, 2017, 2016 2015: December 31, 2017 2016 2015 Weighted average grant date fair value per option granted $ 0.18 $ 0.08 $ 0.12 Fair value of options vested 1,192 2,022 1,584 Cash from participants to exercise stock options 1,238 206 13 Intrinsic value of options exercised 2,271 221 8 The following table summarizes the Company ’s stock options outstanding and exercisable by ranges of option prices as of December 31, 2017: Options Outstanding Options Exercisable Range of Exercise Prices Numbers of Options Weighted Average Remaining Contractual Weighted Average Number of Options Weighted Average Remaining Contractual Weighted Average $0.00 - 0.10 13,501,576 6.31 $ 0.08 8,621,021 5.35 $ 0.08 0.11 - 0.468 20,933,418 6.83 0.23 11,610,867 5.92 0.25 Total 34,434,994 20,231,888 The C ompany’s non-vested options at the beginning and ending of fiscal year 2017 $0.13 $0.15 I n connection with the separation of former executives and directors, the Company has modified previously granted equity awards to allow for the acceleration of vesting of equity awards, and the extension of the timing to exercise vested awards, following the respective separation dates. The Company incurred incremental stock-based compensation expense of $261, $367, $13 December 31, 2017, 2016, 2015,

Note 16 - Income Taxes

Note 16 - Income Taxes	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Income Tax Disclosure [Text Block]	1 6 . Income Taxes Significant components of deferred tax assets are as follows: Years Ended December 31, 2017 2016 Loss carry forwards $ 39,304 $ 57,097 Derivative valuations 521 685 NQSO 1,794 2,214 Tax Credits 382 433 Other (54 ) (99 ) Total deferred tax asset 41,947 60,330 Valuation allowance (41,947 ) (60,330 ) Total deferred tax asset, net - - The valuation allowance (decreased) increased $( 18,383 $5,251 2017 2016, December 22, 2017, 34% 21% January 1, 2018. $20,564, The following table accounts for the differences between the expected federal tax benefit (based on the statutory 2017 34% Years Ended December 31, 2017 2016 2015 Expected federal tax benefit -34.0 % -34.0 % -34.0 % Permanent items 1.7 % 5.6 % 0.4 % Net operating loss utilized or expired 0.0 % 0.0 % 0.0 % Increase in valuation allowance and others 32.3 % 28.4 % 33.6 % Effective tax rate 0 % 0 % 0 % As of December 31, 2017, $159.6 2018 2037. 21%. not may 21% 2017. December 31, 2017, $82.8 2018 2037, one not $36.2 2018 2037. We recognize excess tax benefits associated with the exercise of stock options directly to shareholders’ equity only when realized. Accordingly, deferred tax assets are not December 31, 2017, not $406 $406 As of December 31, 2017, $189 2021 2030. $243, not not Section 382 IRC”) imposes limitations on the use of NOL’s and credits following changes in ownership as defined in the IRC. The limitation could reduce the amount of benefits that would be available to offset future taxable income each year, starting with the year of an ownership change. As a result of the completion of the complex analysis required by the IRC to determine if an ownership change has occurred, the Company has determined that its annual NOL carryforward limitation under Section 382 $764 The ability to realize the tax benefits associated with deferred tax assets, which includes benefits related to NOL ’s, is principally dependent upon the Company’s ability to generate future taxable income from operations. The Company has provided a full valuation allowance for its net deferred tax assets due to the Company’s net operating losses. The Company adopted the provisions of FASB ASC Topic 470 – Income Taxes. At the adoption date and as of December 31, 2017, no no $0 December 31, 2017, 2016 2015. As of December 31, 2017, 2013 2017, 2012 2017

Note 17 - Loss Per Common Share

Note 17 - Loss Per Common Share	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Earnings Per Share [Text Block]	1 7 . Loss Per Common Share Basic earnings per share (“EPS”) is computed by dividing earnings (loss) attributable to common shareholders by the weighted average number of common shares outstanding for the periods. Diluted EPS reflects the potential dilution of securities that could share in the earnings. Options to purchase 34,434,994 $0.07 $0.47 December 31, 2017, not 47,582,402 $0.07 $0.77 December 31, 2016, not 41,910,734 $0.08 $1.44 December 31, 2015, not Warrants to purchase 10,066,809 $0.07 December 31, 2017 not 41,924,653 $0.07 $0.17 December 31, 2016 not 36,509,931 $0.17 $0.19 December 31, 2015 not

Note 18 - Segment Information

Note 18 - Segment Information	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	1 8 . Segment Information The primary business of the Co mpany is to develop and manufacture products and applications from amorphous alloys. As a result, the Company’s financial results are reported in a single

Note 19 - Commitments and Conti

Note 19 - Commitments and Contingencies	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	19 . Commitments and Contingencies Alloy Purchase Commitments As of December 31, 2017, twelve 12 $308 December 31, 2017. Operating Lease Commitments The Company previously leased its offices and warehouse facilities under various lease agreements, certain of which were subject to escalations based upon increases in specified operating expenses or increases in the Consumer Price Index. During June 2017, June 30, 2017. $125, $17, December 31, 2017. $30. December 31, 2017, no Rent expense was $130, $225, $225 December 31, 2017, 2016, 2015,

Note 20 - 401(k) Savings Plan

Note 20 - 401(k) Savings Plan	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Pension and Other Postretirement Benefits Disclosure [Text Block]	20 . 401 The Company has a tax-qualified employee savings and retirement plan, or 401 . Under the 401 may 15% 401 401 401 not 401

Note 21 - Related Party Transac

Note 21 - Related Party Transactions	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	21 . Related Party Transactions On November 17, 2016, the Company and Thomas Steipp, the Company’s former President and Chief Executive Officer, entered into a Separation and Mutual Release Agreement pursuant to which Mr. Steipp resigned as an officer, director, and employee of the Company (the “Separation Agreement”). The Separation Agreement provided for the payment of severance compensation to Mr. Steipp in the form of a lump sum of $3 00 12 3,990,400 second 10,777,949 $297 December 31, 2016. December 31, 2017 December 31, 2016, $0 $301, On August 16, 2017, ’s former Chief Financial Officer, entered into a Separation Agreement and General Release pursuant to which Mr. Chung resigned as an officer and employee of the Company (the “Tony Chung Separation Agreement”). The Tony Chung Separation Agreement provided for the payment of severance compensation to Mr. Chung in the form of a continuation of his base annual salary of $240 12 12 247,650 first 2,889,749 $89 December 31, 2017 . In connection with the Tony Chung Separation Agreement, Mr. Chung and the Company granted each other mutual general releases subject to customary exceptions. As of December 31, 2017 December 31, 2016, $164 $0, On March 10, 2016, 2016 405,000,000 ’s common stock for an aggregate purchase price of $63,400. 2016 March 10, 2016, December 31, 2017, 5% $877, $68, $0 December 31, 2017, 2016, 2015,

Note 22 - Quarterly Financial I

Note 22 - Quarterly Financial Information (Unaudited)	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Quarterly Financial Information [Text Block]	22 . Quarterly Financial Information (Unaudited) (in thousands, except per share data) Quarter Ended March 31, 2017 June 30, 2017 September 30, 2017 December 31, 2017 Total Revenue $ 48 $ 58 $ 36 $ 179 $ 321 Gross profit (loss) (14 ) (9 ) (51 ) (301 ) $ (375 ) Operating loss (2,109 ) (1,797 ) (2,290 ) (2,406 ) $ (8,602 ) Net loss and comprehensive loss (945 ) (3,821 ) (3,951 ) 27 $ (8,690 ) Basic and diluted net loss per common share $ (0.00 ) $ (0.00 ) $ (0.00 ) $ 0.00 $ (0.01 ) Quarter Ended March 31, 2016 June 30, 2016 September 30, 2016 December 31, 2016 Total Revenue $ 168 $ 34 $ 154 $ 124 $ 480 Gross profit (loss) 10 21 (11 ) (93 ) $ (73 ) Operating loss (2,566 ) (2,367 ) (2,238 ) (2,716 ) $ (9,887 ) Net loss and comprehensive loss (9,178 ) (824 ) (3,802 ) (4,948 ) $ (18,752 ) Basic and diluted net loss per common share $ (0.02 ) $ (0.00 ) $ (0.01 ) $ (0.00 ) $ (0.03 )

Schedule II - Valuation and Qua

Schedule II - Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]	LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES Valuation and Qualifying Accounts (in $ thousands) Balance at Additions Charged to Balance Beginning Costs and Other at End Year ended December 31, 2017 of Period Expenses Accounts Deductions of Period Uncollectible accounts - - - - - Deferred tax asset valuation allowance 60,330 2,834 - (21,217 ) 41,947 Total $ 60,330 $ 2,834 $ 0 $ (21,217 ) $ 41,947 Year ended December 31, 2016 Uncollectible accounts - - - - - Deferred tax asset valuation allowance 55,079 6,675 - (1,424 ) 60,330 Total $ 55,079 $ 6,675 $ 0 $ (1,424 ) $ 60,330 Year ended December 31, 2015 Uncollectible accounts - 19 - (19 ) - Deferred tax asset valuation allowance 54,948 4,451 - (4,320 ) 55,079 $ 54,948 $ 4,470 $ 0 $ (4,339 ) $ 55,079 84

Significant Accounting Policies

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation. The consolidated financial statements include the accounts of Liquidmetal Technologies, Inc., its special-purpose wholly-owned subsidiary, Crucible Intellectual Property, 20321
Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]	Non- C ontrolling I nterest.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition . Revenue is recognized pursuant to applicable accounting standards including FASB ASC Topic 605 605” 605 The Company ’s revenue recognition policy complies with the requirements of ASC 605. not not License revenue arrangements in general provide for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include the grant of an exclusive or non-exclusive right to manufacture and/or sell products covered by patented technologies owned or controlled by the Company. The intellectual property rights granted may Licensing revenues that are one upon the granting of the license are recognized when i) the license term begins in a manner consistent with the nature of the transaction and the earnings process is complete, ii) when collectability is reasonably assured or upon receipt of an upfront fee, and iii) when all other revenue recognition criteria have been met. Pursuant to the terms of these agreements, the Company has no
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash. The Company considers all highly liquid investments with maturity dates of three not December 31, 2017 2016, no
Receivables, Policy [Policy Text Block]	Trade Accounts Receivable. The Company grants credit to its customers generally in the form of short-term trade accounts receivable. The creditworthiness of customers is evaluated prior to signing a contract with the customer. As of December 31, 2017, three 84%, $131, December 31, 2016, two 100%, $95, During 2017, five 63% 2016, three 73% 2015, three 52% may The allowance for doubtful accounts reflects management's best estimate of probable losses inherent in the trade accounts receivable. Management primarily determines the allowance based on the aging of accounts receivable balances, historical write-off experience, customer concentrations, customer creditworthiness and current industry and economic trends. The Company's provisions for uncollectible receivables are included in selling, marketing, general and administrative expense in the consolidated statements of operations and comprehensive loss. At December 31, 2017 2016, not
Inventory, Policy [Policy Text Block]	Inventory. Inventory is stated at the lower of weighted-average cost or net realizable value. Inventory is recorded at actual cost when purchased and then expensed at weighted-average cost as used in production and/or shipped to satisfy customer orders. We perform an analysis of our inventory balances at least quarterly to determine if the carrying amount of inventories exceeds their net realizable value. The analysis of estimated net realizable value is based on customer orders, market trends and historical pricing. If the carrying amount exceeds the estimated net realizable value, the carrying amount is reduced to the estimated net realizable value.
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment. Property and equipment are stated at cost less accumulated depreciation and amortization. Additions and major renewals are capitalized. Repairs and maintenance are charged to expense as incurred. Upon disposal, the related cost and accumulated depreciation are removed from the accounts, with the resulting gain or loss included in operating income. Depreciation is provided principally on the straight-line method over the estimated useful lives of the assets, which range from one five
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]	Intangible A ssets. Intangible assets consist of the costs incurred to purchase patent rights and costs incurred to register and maintain patents and trademarks. Intangible assets are reported at cost, net of accumulated amortization. Patents and trademarks are amortized using the straight-line method over a period based on their contractual lives ranging from ten seventeen
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of Long-lived Assets . The Company reviews long-lived assets to be held and used in operations for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may may no December 31, 2017, 2016, 2015,
Fair Value Measurement, Policy [Policy Text Block]	Fair Value Measurements. The estimated fair values of financial instruments reported in the consolidated financial statements have been determined using available market information and valuation methodologies, as applicable. The fair value of cash and restricted cash approximate their carrying value due to their short maturities and are classified as Level 1 Fair value is defined as the exchange price that would be received for an asset o r paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Entities are required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value based upon the following fair value hierarchy: Level 1 — Quoted prices in active markets for identical assets or liabilities; Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not Level 3 — Unobservable inputs that are supported by little or no The Company has several financial instruments, namely warrant liabilities that are recorded at fair value on a periodic basis using Level 2 480 10, 815 25 1 815 10 15 74 11 12 As of December 31, 2017, Fair Value Level 1 Level 2 Level 3 Warrant liabilities (current) - - - - Warrant liabilities (long-term) 2,192 - 2,192 - As of December 31, 2016, Fair Value Level 1 Level 2 Level 3 Warrant liabilities (current) 2,224 - 2,224 - Warrant liabilities (long-term) 2,047 - 2,047 -
Research and Development Expense, Policy [Policy Text Block]	Research and Development Expenses. Research and development expenses represent salaries, related benefits expense, expenses incurred for the design and testing of new processing methods and other expenses related to the research and development of Liquidmetal alloys. Development costs incurred in research and development activities are expensed as incurred.
Advertising Costs, Policy [Policy Text Block]	Advertising and Promotion Expenses. Advertising and promotion expenses are expensed when incurred. Advertising and promotion expenses were $154, $83 $76, December 31, 2017, 2016 2015,
Legal Costs, Policy [Policy Text Block]	Legal Costs. Legal costs are expensed as incurred.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation . The Company accounts for share-based compensation in accordance with the fair value recognition provisions of FASB ASC Topic 718, Share-based Payment may
Income Tax, Policy [Policy Text Block]	Income Taxes. Income taxes are provided under the asset and liability method as required by FASB ASC Topic 740, Accounting for Income Taxes Under the provisions of FASB ASC Topic 740, no no no December 31, 2017, 2016 2015,
Earnings Per Share, Policy [Policy Text Block]	Earnings Per Share. Basic earnings per share (“EPS”) is computed by dividing earnings (losses) attributable to common shareholders by the weighted average number of common shares outstanding for the periods. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates. These management estimates are primarily related to impairment of long-lived assets, allowance for bad debt, warrant valuations, and inventory valuation.
Subsequent Events, Policy [Policy Text Block]	Subsequent Events. The Company evaluated subsequent events through the filing of its Annual Report on Form 10
Supplemental Cash Flow Information, Policy [Policy Text Block]	Supplemental Cash Flow Information. Cash payments for interest were $ 0, $9, $4 December 31, 2017, 2016, 2015,
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements. Leases In February 2016, December 15, 2018 not Revenue from Contracts with Customers In May 2014, for fiscal and interim periods beginning after December 15, 2017 not Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA and the SEC did not not

Note 2 - Summary of Significa31

Note 2 - Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Fair Value Level 1 Level 2 Level 3 Warrant liabilities (current) - - - - Warrant liabilities (long-term) 2,192 - 2,192 - Fair Value Level 1 Level 2 Level 3 Warrant liabilities (current) 2,224 - 2,224 - Warrant liabilities (long-term) 2,047 - 2,047 -

Note 4 - Trade Accounts Recei32

Note 4 - Trade Accounts Receivable (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	December 31, 2017 2016 Trade accounts receivable $ 157 $ 95 Less: Allowance for doubtful accounts - - Trade accounts receivable, net $ 157 $ 95

Note 5 - Prepaid Expenses and33

Note 5 - Prepaid Expenses and Other Current Assets (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Prepaid Expenses and Other Current Assets [Table Text Block]	December 31, 2017 2016 Prepaid service invoices $ 116 $ 65 Prepaid manufacturing and mold costs - 27 Prepaid insurance premiums 210 220 Total 326 312

Note 6 - Inventory (Tables)

Note 6 - Inventory (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Inventory, Current [Table Text Block]	December 31, 2017 2016 Raw materials $ 367 $ 350 Work in progress 24 25 Finished goods - 15 Total 391 390

Note 7 - Property and Equipme35

Note 7 - Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Property, Plant and Equipment [Table Text Block]	December 31, 2017 2016 Land, building, and improvements $ 8,947 $ - Machinery and equipment 5,577 $ 2,725 Computer equipment 253 236 Office equipment, furnishings, and improvements 181 564 Total 14,958 3,525 Accumulated depreciation (2,493 ) (2,386 ) Total property and equipment, net $ 12,465 $ 1,139

Note 8 - Patents and Trademar36

Note 8 - Patents and Trademarks, Net (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Finite-Lived Intangible Assets [Table Text Block]	December 31, 2017 2016 Purchased and licensed patent rights $ 566 $ 566 Internally developed patents 1,686 1,686 Trademarks 148 148 Total 2,400 2,400 Accumulated amortization $ (1,992 ) $ (1,906 ) Total intangible assets, net $ 408 $ 494
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	December 31, Aggregate Amortization Expense 2018 $ 86 2019 84 2020 81 2021 56 2022 29 Thereafter 72 Total $ 408
Finite-lived Intangible Assets, Accumulated Amortization [Table Text Block]	December 31, 2017 2016 Purchased and licensed patent rights $ (541 ) $ (534 ) Internally developed patents (1,326 ) (1,253 ) Trademarks (125 ) (119 ) Total $ (1,992 ) $ (1,906 )
Finite-lived Intangible Assets, Weighted Average Amortization Periods [Table Text Block]	December 31, 2017 2016 Purchased and licensed patent rights 17 17 Internally developed patents 17 17 Trademarks 10 10

Note 10 - Accrued Liabilities (

Note 10 - Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Accrued Liabilities [Table Text Block]	December 31, 2017 2016 Accrued payroll, vacation, and bonuses $ 149 $ 606 Accrued severance 164 301 Accrued audit fees 52 72 Straight-line rent accruals - 91 Total 365 1,070

Note 11 - Warrant Liabilities (

Note 11 - Warrant Liabilities (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Fair Value Assumptions used for Warrants Outstanding [Table Text Block]	December 31, 2017 2016 Expected life in years 8.19 0.42 - 9.19 Volatility 111% 76% - 122% Risk-free interest rate 2.4% 0.6% - 2.5% Dividend rate 0% 0
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Number of Shares Exercise Price Expiration Date 10,066,809 $ 0.07 March 10, 2026 10,066,809
Warrant [Member]
Notes Tables
Schedule of Derivative Liabilities at Fair Value [Table Text Block]	Visser MTA July 2, 2012 2016 Purchase Agreement Private Placement Agreement Total Ending Balance - December 31, 2016 $ 1,528 $ 696 $ 2,047 $ 4,271 Change in value of warrant liability, (gain) loss (553 ) 551 145 143 Exercises (975 ) (1,247 ) - (2,222 ) Ending Balance - December 31, 2017 $ - $ - $ 2,192 $ 2,192 Included in current liabilities $ - $ - $ - $ - Included in long-term liabilities $ - $ - $ 2,192 $ 2,192

Note 15 - Stock Compensation 39

Note 15 - Stock Compensation Plan (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	December 31, 2017 2016 2015 Expected volatility 45.20% - 107.54% 56.48% - 115.39% 84.19% - 168.46% Expected dividends - - - Expected term (in years) .123 - 5.85 1.00 - 6.32 0.73 - 6.32 Risk-free rate 0.82% - 2.06% 0.76% - 2.13% 0.39% - 1.96%
Share-based Compensation, Stock Options, Activity [Table Text Block]	Number of Shares Weighted Average Exercise Price Weighted Average Aggregate Intrinsic Value (in thousands) Options outstanding at December 31, 2015 41,910,734 0.21 Granted 23,064,401 0.10 Exercised (2,197,199 ) 0.09 Forfeited (12,931,033 ) 0.14 Expired (2,264,501 ) 0.19 Options outstanding at December 31, 2016 47,582,402 0.15 Granted 4,899,393 0.20 Exercised (10,978,664 ) 0.11 Forfeited (7,052,137 ) 0.15 Expired (16,000 ) 0.77 Options outstanding at December 31, 2017 34,434,994 $ 0.17 6.6 $ 2,685 Options exercisable at December 31, 2017 20,231,888 $ 0.17 5.7 $ 1,607 Options unvested at December 31, 2017 14,203,106 $ 0.17 8.0 $ 1,078 Options vested or expected to vest at December 31, 2017 32,763,190 $ 0.17 6.5 $ 2,564
Schedule of Supplemental Stock Option Data [Table Text Block]	December 31, 2017 2016 2015 Weighted average grant date fair value per option granted $ 0.18 $ 0.08 $ 0.12 Fair value of options vested 1,192 2,022 1,584 Cash from participants to exercise stock options 1,238 206 13 Intrinsic value of options exercised 2,271 221 8
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	Options Outstanding Options Exercisable Range of Exercise Prices Numbers of Options Weighted Average Remaining Contractual Weighted Average Number of Options Weighted Average Remaining Contractual Weighted Average $0.00 - 0.10 13,501,576 6.31 $ 0.08 8,621,021 5.35 $ 0.08 0.11 - 0.468 20,933,418 6.83 0.23 11,610,867 5.92 0.25 Total 34,434,994 20,231,888

Note 16 - Income Taxes (Tables)

Note 16 - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	Years Ended December 31, 2017 2016 Loss carry forwards $ 39,304 $ 57,097 Derivative valuations 521 685 NQSO 1,794 2,214 Tax Credits 382 433 Other (54 ) (99 ) Total deferred tax asset 41,947 60,330 Valuation allowance (41,947 ) (60,330 ) Total deferred tax asset, net - -
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	Years Ended December 31, 2017 2016 2015 Expected federal tax benefit -34.0 % -34.0 % -34.0 % Permanent items 1.7 % 5.6 % 0.4 % Net operating loss utilized or expired 0.0 % 0.0 % 0.0 % Increase in valuation allowance and others 32.3 % 28.4 % 33.6 % Effective tax rate 0 % 0 % 0 %

Note 22 - Quarterly Financial41

Note 22 - Quarterly Financial Information (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Quarterly Financial Information [Table Text Block]	Quarter Ended March 31, 2017 June 30, 2017 September 30, 2017 December 31, 2017 Total Revenue $ 48 $ 58 $ 36 $ 179 $ 321 Gross profit (loss) (14 ) (9 ) (51 ) (301 ) $ (375 ) Operating loss (2,109 ) (1,797 ) (2,290 ) (2,406 ) $ (8,602 ) Net loss and comprehensive loss (945 ) (3,821 ) (3,951 ) 27 $ (8,690 ) Basic and diluted net loss per common share $ (0.00 ) $ (0.00 ) $ (0.00 ) $ 0.00 $ (0.01 ) Quarter Ended March 31, 2016 June 30, 2016 September 30, 2016 December 31, 2016 Total Revenue $ 168 $ 34 $ 154 $ 124 $ 480 Gross profit (loss) 10 21 (11 ) (93 ) $ (73 ) Operating loss (2,566 ) (2,367 ) (2,238 ) (2,716 ) $ (9,887 ) Net loss and comprehensive loss (9,178 ) (824 ) (3,802 ) (4,948 ) $ (18,752 ) Basic and diluted net loss per common share $ (0.02 ) $ (0.00 ) $ (0.01 ) $ (0.00 ) $ (0.03 )

Schedule II - Valuation and Q42

Schedule II - Valuation and Qualifying Accounts (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Summary of Valuation and Qualifying Accounts [Table Text Block]	Balance at Additions Charged to Balance Beginning Costs and Other at End Year ended December 31, 2017 of Period Expenses Accounts Deductions of Period Uncollectible accounts - - - - - Deferred tax asset valuation allowance 60,330 2,834 - (21,217 ) 41,947 Total $ 60,330 $ 2,834 $ 0 $ (21,217 ) $ 41,947 Year ended December 31, 2016 Uncollectible accounts - - - - - Deferred tax asset valuation allowance 55,079 6,675 - (1,424 ) 60,330 Total $ 55,079 $ 6,675 $ 0 $ (1,424 ) $ 60,330 Year ended December 31, 2015 Uncollectible accounts - 19 - (19 ) - Deferred tax asset valuation allowance 54,948 4,451 - (4,320 ) 55,079 $ 54,948 $ 4,470 $ 0 $ (4,339 ) $ 55,079

Note 2 - Summary of Significa43

Note 2 - Summary of Significant Accounting Policies (Details Textual) $ in Thousands	12 Months Ended
	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)
Cash Equivalents, at Carrying Value	$ 0	$ 0
Accounts Receivable, Gross, Current	157	95
Allowance for Doubtful Accounts Receivable, Current	0	0
Impairment of Long-Lived Assets Held-for-use	0	0	$ 0
Advertising Expense	154	83	76
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense	0	0	0
Interest Paid	$ 0	9	$ 4
Minimum [Member]
Property, Plant and Equipment, Useful Life	1 year
Finite-Lived Intangible Asset, Useful Life	10 years
Maximum [Member]
Property, Plant and Equipment, Useful Life	5 years
Finite-Lived Intangible Asset, Useful Life	17 years
Customer Concentration Risk [Member] | Three Major Customers [Member]
Accounts Receivable, Gross, Current	$ 131
Customer Concentration Risk [Member] | Two Major Customers [Member]
Accounts Receivable, Gross, Current		$ 95
Customer Concentration Risk [Member] | Accounts Receivable [Member]
Concentration Risk, Number of Major Customers	3	2
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Three Major Customers [Member]
Concentration Risk, Percentage	84.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Two Major Customers [Member]
Concentration Risk, Percentage		100.00%
Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member]
Concentration Risk, Number of Major Customers	5	3	3
Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member] | Three Major Customers [Member]
Concentration Risk, Percentage		73.00%	52.00%
Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member] | Five Major Customers [Member]
Concentration Risk, Percentage	63.00%

Note 2 - Summary of Significa44

Note 2 - Summary of Significant Accounting Policies - Fair Value of Items Measured on a Recurring Basis (Details) - Warrant [Member] - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Derivative Liability, Current		$ 2,224
Derivative Liability, Noncurrent	2,192	2,047
Fair Value, Measurements, Recurring [Member]
Derivative Liability, Current		2,224
Derivative Liability, Noncurrent	2,192	2,047
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Derivative Liability, Current
Derivative Liability, Noncurrent
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Derivative Liability, Current		2,224
Derivative Liability, Noncurrent	2,192	2,047
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Derivative Liability, Current
Derivative Liability, Noncurrent

Note 3 - Significant Transact45

Note 3 - Significant Transactions (Details Textual)	Feb. 16, 2017USD ($)ft²	Oct. 26, 2016USD ($)$ / sharesshares	Aug. 25, 2016USD ($)	Mar. 10, 2016USD ($)$ / sharesshares	Mar. 09, 2016USD ($)$ / sharesshares	Aug. 22, 2014USD ($)$ / sharesshares	Aug. 20, 2014USD ($)$ / shares	Dec. 06, 2013	Nov. 08, 2013USD ($)shares	Jul. 17, 2013shares	Jan. 31, 2012	Feb. 28, 2015USD ($)	Dec. 31, 2017USD ($)$ / sharesshares	Sep. 30, 2015USD ($)$ / sharesshares	Dec. 31, 2017USD ($)$ / sharesshares	Dec. 31, 2016USD ($)$ / sharesshares	Dec. 31, 2015USD ($)shares	Dec. 31, 2014USD ($)shares	Mar. 31, 2017USD ($)	Mar. 22, 2017$ / sharesshares	May 19, 2016$ / sharesshares	Jul. 02, 2012USD ($)$ / sharesshares	Jun. 30, 2012$ / sharesshares	Jun. 01, 2012$ / sharesshares
Area of Land | ft²	41,000
Stock Issued During Period, Value, New Issues | $																$ 61,379,000	$ 1,568,000
Common Stock, Par or Stated Value Per Share | $ / shares													$ 0.001		$ 0.001	$ 0.001
Proceeds from Issuance of Common Stock | $																$ 62,650,000	1,568,000
Interest Expense | $																$ 9,000	4,000
Line of Credit [Member]
Line of Credit Facility, Maximum Borrowing Capacity | $												$ 2,000,000
Line of Credit Facility, Interest Rate During Period												2.10%				2.10%
Interest Expense | $													$ 0		$ 0	$ 9,000	$ 4,000
Line of Credit [Member] | Collateral Pledged [Member] | Cash [Member]
Line of Credit Facility, Collateral Fees, Amount | $			$ 1,000,000
Eontec [Member]
Purchase Price for Machinery and Equipment | $																			$ 780,000
Warrants in Connection with the 2016 Purchase Agreement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares				10,066,809
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 0.07		$ 0.07
Warrants in Connection with the 2016 Purchase Agreement [Member] | Vest on March 10, 2016 [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares				2,609,913
Warrants in Connection with the 2016 Purchase Agreement [Member] | Vest on October 26, 2016 [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares		7,456,896
July 2012 Private Placement Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares																						18,750,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares													$ 0.17		$ 0.17	$ 0.17						$ 0.384
Warrants in Connection with Vissar MTA Agreement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares													21,317,094		21,317,094	21,317,094				21,317,094			15,000,000	15,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares													$ 0.16		$ 0.16	$ 0.16				$ 0.16			$ 0.22	$ 0.22
Common Stock [Member]
Stock Issued During Period, Shares, New Issues | shares																405,000,000	12,500,000
Stock Issued During Period, Value, New Issues | $																$ 405,000	$ 13,000
The 2016 Purchase Agreement [Member]
Common Stock Purchase Agreement, Number of Shares Authorized to Issue and Sell to Investors | shares				405,000,000
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors | $				$ 63,400,000
Stock Issued During Period, Shares, New Issues | shares		300,000,000		105,000,000
Stock Issued During Period, Value, New Issues | $		$ 55,000,000		$ 8,400,000
Sale of Stock, Price Per Share | $ / shares				$ 0.08
Common Stock Purchase Agreement, Purchase Price per Share, After Satisfaction of Certain Conditions | $ / shares		$ 0.15																			$ 0.15
Common Stock Purchase Agreement, the Other Purchase Price per Share, No Later than 90 Days after Satisfaction of Certain Conditions | $ / shares		$ 0.25																			$ 0.25
Common Stock Purchase Agreement, Value of Shares Authorized to Be Purchased No Later than 90 Days after Satisfaction of Certain Conditions | $		$ 55,000,000
The 2016 Purchase Agreement [Member] | Common Stock, Purchase Price per Share of $0.15 [Member]
Stock Issued During Period, Shares, New Issues | shares		200,000,000
Sale of Stock, Price Per Share | $ / shares		$ 0.15
Common Stock Purchase Agreement, Remaining Number of Shares to be Purchased, After the Satisfaction of Certain Conditions | shares		200,000,000																			200,000,000
The 2016 Purchase Agreement [Member] | Common Stock, Purchase Price per Share of $0.25 [ Member]
Stock Issued During Period, Shares, New Issues | shares		100,000,000
Sale of Stock, Price Per Share | $ / shares		$ 0.25
Common Stock Purchase Agreement, Remaining Number of Shares to be Purchased, After the Satisfaction of Certain Conditions | shares		100,000,000																			100,000,000
The 2014 Purchase Agreement [Member]
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors | $							$ 30,000,000
Stock Issued During Period, Shares, New Issues | shares														12,500,000
Common Stock, Par or Stated Value Per Share | $ / shares							$ 0.001
Common Stock Subscriptions, Term							3 years
Proceeds from Issuance of Common Stock | $					$ 1,568,000									$ 1,568,000
The 2014 Purchase Agreement [Member] | Common Stock [Member]
Stock Issued During Period, Shares, New Issues | shares					12,500,000
Stock Issued During Period, Weighted Average Price Per Share | $ / shares					$ 0.13									$ 0.13
Common Stock Purchase Agreement [Member]
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors | $									$ 20,000,000
Stock Issued During Period, Shares, New Issues | shares						85,355,615												85,355,615
Stock Issued During Period, Value, New Issues | $						$ 16,000,000												$ 16,000,000
Common Stock Subscriptions, Term									3 years
Stock Issued During Period, Weighted Average Price Per Share | $ / shares						$ 0.19
Stock Issued During Period, Shares, Other | shares									2,666,667
Private Placement [Member] | Convertible Notes Payable [Member]
Debt Instrument, Face Amount | $																						$ 12,000,000
Debt Instrument, Convertible, Conversion Price | $ / shares																						$ 0.352
Debt Instrument, Interest Rate, Stated Percentage																						8.00%
Debt Conversion, Converted Instrument, Shares Issued | shares										163,641,547
Liquidmetal Golf [Member]
Noncontrolling Interest, Ownership Percentage by Parent													79.00%		79.00%
Liquidmetal Technology Limited [Member] | Lugee Li [Member]
Ownership Percentage				100.00%
Valencia Circle, LLC [Member]
Payments to Acquire Buildings | $	$ 7,818,000
Engel [Member]
Supply and License Agreement, Term											5 years
Exclusive License Agreement, Term								10 years

Note 4 - Trade Accounts Recei46

Note 4 - Trade Accounts Receivable - Trade Accounts Receivable Table (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Trade accounts receivable	$ 157	$ 95
Less: Allowance for doubtful accounts	0	0
Trade accounts receivable, net	$ 157	$ 95

Note 5 - Prepaid Expenses and47

Note 5 - Prepaid Expenses and Other Current Assets (Details Textual) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Prepaid Expense and Other Assets, Current	$ 326	$ 312

Note 5 - Prepaid Expenses and48

Note 5 - Prepaid Expenses and Other Current Assets - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Prepaid service invoices	$ 116	$ 65
Prepaid manufacturing and mold costs		27
Prepaid insurance premiums	210	220
Total	$ 326	$ 312

Note 6 - Inventory (Details Tex

Note 6 - Inventory (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Inventory, Net	$ 391	$ 390
Inventory Write-down	$ 279

Note 6 - Inventory - Schedule o

Note 6 - Inventory - Schedule of Inventory (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Raw materials	$ 367	$ 350
Work in progress	24	25
Finished goods		15
Total	$ 391	$ 390

Note 7 - Property and Equipme51

Note 7 - Property and Equipment (Details Textual)	Feb. 16, 2017USD ($)ft²	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Mar. 31, 2017USD ($)
Depreciation		$ 548,000	$ 429,000	$ 423,000
Eontec [Member]
Purchase Price for Machinery and Equipment					$ 780,000
Valencia Circle, LLC [Member]
Area of Real Estate Property | ft²	41,000
Payments to Acquire Buildings	$ 7,818,000
Cost of Sales [Member]
Depreciation		42,000	20,000	29,000
Selling, General and Administrative Expenses [Member]
Depreciation		$ 506,000	$ 409,000	$ 394,000

Note 7 - Property and Equipme52

Note 7 - Property and Equipment - Property and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Property and equipment, gross	$ 14,958	$ 3,525
Accumulated depreciation	(2,493)	(2,386)
Total property and equipment, net	12,465	1,139
Land, Buildings and Improvements [Member]
Property and equipment, gross	8,947
Machinery and Equipment [Member]
Property and equipment, gross	5,577	2,725
Computer Equipment [Member]
Property and equipment, gross	253	236
Office Equipment, Furnishings and Improvements [Member]
Property and equipment, gross	$ 181	$ 564

Note 8 - Patents and Trademar53

Note 8 - Patents and Trademarks, Net (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Amortization of Intangible Assets	$ 86	$ 98	$ 99

Note 8 - Patents and Trademar54

Note 8 - Patents and Trademarks, Net - Patents and Trademarks (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Intangible assets, gross	$ 2,400	$ 2,400
Accumulated amortization	(1,992)	(1,906)
Total	408	494
Purchased and Licensed Patent Rights [Member]
Intangible assets, gross	566	566
Accumulated amortization	(541)	(534)
Internally Developed Patents [Member]
Intangible assets, gross	1,686	1,686
Accumulated amortization	(1,326)	(1,253)
Trademarks [Member]
Intangible assets, gross	148	148
Accumulated amortization	$ (125)	$ (119)

Note 8 - Patents and Trademar55

Note 8 - Patents and Trademarks, Net - Estimated Future Aggregate Amortization Expense (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
2,018	$ 86
2,019	84
2,020	81
2,021	56
2,022	29
Thereafter	72
Total	$ 408	$ 494

Note 8 - Patents and Trademar56

Note 8 - Patents and Trademarks, Net - Accumulated Amortization (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Accumulated amortization	$ (1,992)	$ (1,906)
Purchased and Licensed Patent Rights [Member]
Accumulated amortization	(541)	(534)
Internally Developed Patents [Member]
Accumulated amortization	(1,326)	(1,253)
Trademarks [Member]
Accumulated amortization	$ (125)	$ (119)

Note 8 - Patents and Trademar57

Note 8 - Patents and Trademarks, Net - Weighted Average Amortization Periods (Details)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Purchased and Licensed Patent Rights [Member]
Weighted average amortization periods (Year)	17 years	17 years
Internally Developed Patents [Member]
Weighted average amortization periods (Year)	17 years	17 years
Trademarks [Member]
Weighted average amortization periods (Year)	10 years	10 years

Note 9 - Short-term Debt (Detai

Note 9 - Short-term Debt (Details Textual) - USD ($)	1 Months Ended	6 Months Ended	12 Months Ended
	Feb. 28, 2015	Dec. 31, 2017	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Short-term Debt		$ 0	$ 0	$ 0
Interest Expense				9,000	$ 4,000
Line of Credit [Member]
Short-term Debt		0	0	$ 0
Line of Credit Facility, Interest Rate During Period	2.10%			2.10%
Interest Expense		$ 0	$ 0	$ 9,000	$ 4,000

Note 10 - Accrued Liabilities59

Note 10 - Accrued Liabilities (Details Textual) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Accrued Liabilities, Current	$ 365	$ 1,070

Note 10 - Accrued Liabilities -

Note 10 - Accrued Liabilities - Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Accrued payroll, vacation, and bonuses	$ 149	$ 606
Accrued severance	164	301
Accrued audit fees	52	72
Straight-line rent accruals		91
Total	$ 365	$ 1,070

Note 11 - Warrant Liabilities61

Note 11 - Warrant Liabilities (Details Textual) - USD ($)	Mar. 22, 2017	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Oct. 26, 2016	Mar. 10, 2016	Jul. 02, 2012	Jun. 30, 2012	Jun. 01, 2012
Stock Issued During Period, Value, Warrants Exercised in Period		$ 2,934,000	$ 665,000
Fair Value Adjustment of Warrants		143,000	4,117,000	$ (1,946,000)
Proceeds from Warrant Exercises		$ 712,000
Class of Warrant or Right, Outstanding		10,066,809	41,924,653
Warrant [Member]
Derivative Liability, Noncurrent		$ 2,192,000	$ 2,047,000
Decrease in Warrant Liability, Warrants Exercised		2,222,000
Fair Value Adjustment of Warrants		$ 143,000
Fair Value Assumptions, Expected Term		8 years 69 days
Fair Value Assumptions, Expected Volatility Rate		111.00%
Fair Value Assumptions, Risk Free Interest Rate		2.40%
Fair Value Assumptions, Expected Dividend Rate		0.00%	0.00%
Common Stock [Member]
Stock Issued During Period, Shares, Warrants Exercised in Period		11,699,288	1,743,480
Stock Issued During Period, Value, Warrants Exercised in Period		$ 12,000	$ 2,000
Additional Paid-in Capital [Member]
Stock Issued During Period, Value, Warrants Exercised in Period		$ 2,922,000	$ 663,000
Warrants in Connection with Vissar MTA Agreement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	21,317,094	21,317,094	21,317,094					15,000,000	15,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.16	$ 0.16	$ 0.16					$ 0.22	$ 0.22
Derivative Liability, Noncurrent								$ 4,260,000
Class of Warrant or Right, Exercised During Period	21,317,094
Stock Issued During Period, Shares, Warrants Exercised in Period	4,241,386
Decrease in Warrant Liability, Warrants Exercised	$ 975,000
Fair Value Adjustment of Warrants		$ (553,000)	$ 1,494,000	(1,019,000)
Warrants in Connection with Vissar MTA Agreement [Member] | Common Stock [Member]
Stock Issued During Period, Value, Warrants Exercised in Period	4,000
Warrants in Connection with Vissar MTA Agreement [Member] | Additional Paid-in Capital [Member]
Stock Issued During Period, Value, Warrants Exercised in Period	$ 971,000
July 2012 Private Placement Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights							18,750,000
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.17	$ 0.17				$ 0.384
Stock Issued During Period, Shares, Warrants Exercised in Period		7,457,902
Decrease in Warrant Liability, Warrants Exercised		$ 1,247,000
Fair Value Adjustment of Warrants		$ 551,000	$ 1,336,000	(927,000)
Class Of Warrant Or Right Exercised in Period		10,540,750
Proceeds from Warrant Exercises		$ 712,000
July 2012 Private Placement Warrants [Member] | Warrant [Member]
Derivative Liability, Noncurrent							$ 5,053,000
Warrants in Connection with the 2016 Purchase Agreement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						10,066,809
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 0.07	$ 0.07
Fair Value Adjustment of Warrants		$ 145,000	$ 1,287,000	$ 0
Fair Value Assumptions, Expected Term		8 years 69 days
Fair Value Assumptions, Expected Volatility Rate		111.00%
Fair Value Assumptions, Risk Free Interest Rate		2.40%
Fair Value Assumptions, Expected Dividend Rate		0.00%
Warrants in Connection with the 2016 Purchase Agreement [Member] | Warrant [Member]
Derivative Liability, Noncurrent		$ 2,192,000				$ 760,000

Note 11 - Warrant Liabilities -

Note 11 - Warrant Liabilities - Summary of Changes in Warrant Liabilities (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Loss (gain) from change in value of warrants	$ 143,000	$ 4,117,000	$ (1,946,000)
Warrant [Member]
Derivative liabilities, balance	4,271,000
Loss (gain) from change in value of warrants	143,000
Exercises	(2,222,000)
Derivative liabilities, balance	2,192,000	4,271,000
Derivative Liability, Current		2,224,000
Derivative Liability, Noncurrent	2,192,000	2,047,000
Warrant [Member] | Visser MTA Agreement [Member]
Derivative liabilities, balance	1,528,000
Loss (gain) from change in value of warrants	(553,000)
Exercises	(975,000)
Derivative liabilities, balance		1,528,000
Derivative Liability, Current
Derivative Liability, Noncurrent
Warrant [Member] | Private Placement [Member]
Derivative liabilities, balance	696,000
Loss (gain) from change in value of warrants	551,000
Exercises	(1,247,000)
Derivative liabilities, balance		696,000
Derivative Liability, Current
Derivative Liability, Noncurrent
Warrant [Member] | The 2016 Purchase Agreement [Member]
Derivative liabilities, balance	2,047,000
Loss (gain) from change in value of warrants	145,000
Exercises
Derivative liabilities, balance	2,192,000	$ 2,047,000
Derivative Liability, Current
Derivative Liability, Noncurrent	$ 2,192,000

Note 11 - Warrant Liabilities63

Note 11 - Warrant Liabilities - Fair Value Assumptions Used to Determine the Value of Warrants Outstanding (Details) - Warrant [Member]	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Expected life in years (Year)	8 years 69 days
Volatility	111.00%
Risk-free interest rate	2.40%
Dividend rate	0.00%	0.00%
Minimum [Member]
Expected life in years (Year)		153 days
Volatility		76.00%
Risk-free interest rate		0.60%
Maximum [Member]
Expected life in years (Year)		9 years 69 days
Volatility		122.00%
Risk-free interest rate		2.50%

Note 11 - Warrant Liabilities64

Note 11 - Warrant Liabilities - Outstanding Warrants to Acquire Shares of the Common Stock (Details) - $ / shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Number of shares (in shares)	10,066,809	41,924,653
Warrant 1 [Member]
Number of shares (in shares)	10,066,809
Exercise price (in dollars per share)	$ 0.07
Expiration date	Mar. 10, 2026

Note 12 - Option Liabilities (D

Note 12 - Option Liabilities (Details Textual) - USD ($)	Oct. 26, 2016	May 19, 2016	Mar. 10, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Aug. 11, 2016
Fair Value Adjustment of Options					$ 2,613,000
Gain (Loss) on Contract Modification					(2,126,000)
The 2016 Purchase Agreement [Member]
Common Stock Purchase Agreement, Purchase Price per Share, After Satisfaction of Certain Conditions	$ 0.15	$ 0.15
Common Stock Purchase Agreement, the Other Purchase Price per Share, No Later than 90 Days after Satisfaction of Certain Conditions	$ 0.25	$ 0.25
Common Stock Purchase Agreement, Remaining Number of Shares Required to be Purchased before Forfeiture of RIghts							300,000,000
Gain (Loss) on Contract Modification					(2,126,000)
Stock Issued During Period, Shares, New Issues	300,000,000		105,000,000
The 2016 Purchase Agreement [Member] | The 200 Million Share, Call Option [Member]
Original Valuation, Options		$ 489,000
Derivative Liability, Current		2,931,000
The 2016 Purchase Agreement [Member] | The 100 Million Share, Call Option [Member]
Original Valuation, Options		22,000
Derivative Liability, Current		$ 193,000
The 2016 Purchase Agreement [Member] | Call Option [Member]
Fair Value Assumptions, Expected Term		91 days
Fair Value Assumptions, Expected Volatility Rate		85.00%
Fair Value Assumptions, Risk Free Interest Rate		0.31%
Fair Value Assumptions, Expected Dividend Rate		0.00%
Fair Value Adjustment of Options				$ 0	$ 2,613,000
The 2016 Purchase Agreement [Member] | Common Stock, Purchase Price per Share of $0.15 [Member]
Common Stock Purchase Agreement, Remaining Number of Shares to be Purchased, After the Satisfaction of Certain Conditions	200,000,000	200,000,000
Stock Issued During Period, Shares, New Issues	200,000,000
The 2016 Purchase Agreement [Member] | Common Stock, Purchase Price per Share of $0.25 [ Member]
Common Stock Purchase Agreement, Remaining Number of Shares to be Purchased, After the Satisfaction of Certain Conditions	100,000,000	100,000,000
Stock Issued During Period, Shares, New Issues	100,000,000

Note 13 - Other Long-term Lia66

Note 13 - Other Long-term Liabilities (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Other Liabilities, Noncurrent	$ 856	$ 856
Period for Outstanding Liability	5 years

Note 14 - Shareholders' Equity

Note 14 - Shareholders' Equity (Details Textual) - USD ($)	Nov. 08, 2016	Oct. 26, 2016	Mar. 10, 2016	Mar. 09, 2016	Aug. 22, 2014	Nov. 08, 2013	Jul. 02, 2012	Jun. 30, 2012	Sep. 30, 2015	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	May 19, 2016	Jul. 15, 2015	Sep. 09, 2014	Oct. 24, 2013	Feb. 28, 2013	Feb. 27, 2013
Preferred Stock, Shares Outstanding										0	0			0
Common Stock, Shares Authorized										1,100,000,000	1,100,000,000				1,100,000,000			700,000,000	500,000,000	400,000,000
Stock Issued During Period, Value, New Issues											$ 61,379,000	$ 1,568,000
Proceeds from Issuance of Common Stock											62,650,000	$ 1,568,000
Warrants and Rights Outstanding										$ 18,179,000	$ 18,179,000
Warrants in Connection with Series A Preferred Stock Issuance [Member]
Warrants and Rights Outstanding																$ 18,179,000
Investor Identification Agreement [Member]
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs	$ 750,000
Common Stock [Member]
Stock Issued During Period, Shares, New Issues											405,000,000	12,500,000
Conversion of Stock, Shares Issued														16,896,070
Stock Issued During Period, Value, New Issues											$ 405,000	$ 13,000
Series A Preferred Stock [Member]
Conversion of Stock, Shares Converted														506,936
Series A Preferred Stock [Member] | Warrants in Connection with Series A Preferred Stock Issuance [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights																29,779,557
Minimum [Member] | Warrants in Connection with Series A Preferred Stock Issuance [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights																$ 0.48
Maximum [Member] | Warrants in Connection with Series A Preferred Stock Issuance [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights																$ 0.49
Private Placement [Member] | Senior Convertible Notes [Member]
Debt Conversion, Converted Instrument, Shares Issued							163,641,547
Debt Instrument, Periodic Payment, Principal							$ 12,000,000
Debt Instrument, Periodic Payment, Interest							$ 680,000
Private Placement [Member] | Senior Convertible Notes [Member] | Weighted Average [Member]
Debt Instrument, Convertible, Conversion Price							$ 0.0774
Private Placement [Member] | Visser MTA Agreement [Member]
Stock Issued During Period, Shares, New Issues								30,000,000
Common Stock Purchase Agreement [Member]
Stock Issued During Period, Shares, New Issues					85,355,615								85,355,615
Stock Issued During Period, Shares, Other						2,666,667
Stock Issued During Period, Value, New Issues					$ 16,000,000								$ 16,000,000
Stock Issued During Period, Weighted Average Price Per Share					$ 0.19
Common Stock Purchase Agreement [Member] | Weighted Average [Member]
Share Price													$ 0.19
The 2014 Purchase Agreement [Member]
Stock Issued During Period, Shares, New Issues									12,500,000
Common Stock, Shares Covered by Registration Statement																	75,000,000
Proceeds from Issuance of Common Stock				$ 1,568,000					$ 1,568,000
The 2014 Purchase Agreement [Member] | Common Stock [Member]
Stock Issued During Period, Shares, New Issues				12,500,000
Stock Issued During Period, Weighted Average Price Per Share				$ 0.13					$ 0.13
The 2016 Purchase Plan [Member]
Stock Issued During Period, Shares, New Issues			105,000,000
Stock Issued During Period, Value, New Issues			$ 8,400,000
Sale of Stock, Price Per Share			$ 0.08
The 2016 Purchase Agreement [Member]
Stock Issued During Period, Shares, New Issues		300,000,000	105,000,000
Stock Issued During Period, Value, New Issues		$ 55,000,000	$ 8,400,000
Sale of Stock, Price Per Share			$ 0.08
The 2016 Purchase Agreement [Member] | Common Stock, Purchase Price per Share of $0.15 [Member]
Stock Issued During Period, Shares, New Issues		200,000,000
Sale of Stock, Price Per Share		$ 0.15
The 2016 Purchase Agreement [Member] | Common Stock, Purchase Price per Share of $0.25 [ Member]
Stock Issued During Period, Shares, New Issues		100,000,000
Sale of Stock, Price Per Share		$ 0.25

Note 15 - Stock Compensation 68

Note 15 - Stock Compensation Plan (Details Textual) - USD ($)	Aug. 03, 2010	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Jan. 27, 2015	Jun. 28, 2012	Apr. 04, 2002
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number		34,434,994	47,582,402	41,910,734
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		4,899,393	23,064,401
Allocated Share-based Compensation Expense		$ 1,255,000	$ 1,694,000	$ 1,557,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized		$ 1,665,000	$ 2,639,000	$ 3,904,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Forfeiture Rates Minimum		19.86%	8.83%	5.34%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value		$ 0.15	$ 0.13
Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost		$ 261,000	$ 367,000	$ 13,000
Restricted Stock [Member] | Chief Executive Officer [Member]
Allocated Share-based Compensation Expense		$ 0	$ 0	$ 182,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	6,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	5 years
Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant							10,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number		189,000
Equity Incentive Plan 2012 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant						30,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number		21,570,994
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		2,807,262
Equity Incentive Plan 2015 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant					40,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number		12,675,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		2,092,131

Note 15 - Stock Compensation 69

Note 15 - Stock Compensation Plan - Assumptions Used to Estimate Fair Value (Details)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Expected dividends
Minimum [Member]
Expected volatility	45.20%	56.48%	84.19%
Expected term (Year)	44 days	1 year	266 days
Risk-free rate	0.82%	0.76%	0.39%
Maximum [Member]
Expected volatility	107.54%	115.39%	168.46%
Expected term (Year)	5 years 310 days	6 years 116 days	6 years 116 days
Risk-free rate	2.06%	2.13%	1.96%

Note 15 - Stock Compensation 70

Note 15 - Stock Compensation Plan - Summary of Stock Option Transactions (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Options outstanding, number of shares (in shares)	47,582,402	41,910,734
Options outstanding, weighted average exercise price (in dollars per share)	$ 0.15	$ 0.21
Granted, number of shares (in shares)	4,899,393	23,064,401
Granted, weighted average exercise price (in dollars per share)	$ 0.20	$ 0.10
Exercised, number of shares (in shares)	(10,978,664)	(2,197,199)
Exercised, weighted average exercise price (in dollars per share)	$ 0.11	$ 0.09
Forfeited, number of shares (in shares)	(7,052,137)	(12,931,033)
Forfeited, weighted average exercise price (in dollars per share)	$ 0.15	$ 0.14
Expired, number of shares (in shares)	(16,000)	(2,264,501)
Expired, weighted average exercise price (in dollars per share)	$ 0.77	$ 0.19
Options outstanding, number of shares (in shares)	34,434,994	47,582,402
Options outstanding, weighted average exercise price (in dollars per share)	$ 0.17	$ 0.15
Options outstanding, contractual term (Year)	6 years 219 days
Options outstanding, aggregate intrinsic value	$ 2,685
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	20,231,888
Options exercisable, weighted average exercise price (in dollars per share)	$ 0.17
Options exercisable, contractual term (Year)	5 years 255 days
Options exercisable, aggregate intrinsic value	$ 1,607
Options unvested, number of shares (in shares)	14,203,106
Options unvested, weighted average exercise price (in dollars per share)	$ 0.17
Options unvested, contractual term (Year)	8 years
Options unvested, aggregate intrinsic value	$ 1,078
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	32,763,190
Options vested or expected to vest, weighted average exercise price (in dollars per share)	$ 0.17
Options vested or expected to vest, contractual term (Year)	6 years 182 days
Options vested or expected, aggregate intrinsic value	$ 2,564

Note 15 - Stock Compensation 71

Note 15 - Stock Compensation Plan - Supplemental Stock Option Information (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Weighted average grant date fair value per option granted (in dollars per share)	$ 0.18	$ 0.08	$ 0.12
Fair value of options vested	$ 1,192	$ 2,022	$ 1,584
Proceeds from exercise of stock options	1,238	206	13
Intrinsic value of options exercised	$ 2,271	$ 221	$ 8

Note 15 - Stock Compensation 72

Note 15 - Stock Compensation Plan - Summary of Stock Options Outstanding and Exercisable by Ranges of Option Prices (Details)	12 Months Ended
	Dec. 31, 2017$ / sharesshares
Number of options outstanding (in shares) | shares	34,434,994
Number of options exercisable (in shares) | shares	20,231,888
Exercise Price Range 1 [Member]
Range of exercise prices, lower (in dollars per share)	$ 0
Range of exercise prices, upper (in dollars per share)	$ 0.10
Number of options outstanding (in shares) | shares	13,501,576
Options outstanding, weighted average remaining contractual life (Year)	6 years 113 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 0.08
Number of options exercisable (in shares) | shares	8,621,021
Options exercisable, weighted average remaining contractual life (Year)	5 years 127 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 0.08
Exercise Price Range 2 [Member]
Range of exercise prices, lower (in dollars per share)	0.011
Range of exercise prices, upper (in dollars per share)	$ 0.468
Number of options outstanding (in shares) | shares	20,933,418
Options outstanding, weighted average remaining contractual life (Year)	6 years 302 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 0.23
Number of options exercisable (in shares) | shares	11,610,867
Options exercisable, weighted average remaining contractual life (Year)	5 years 335 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 0.25

Note 16 - Income Taxes (Details

Note 16 - Income Taxes (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount		$ (18,383,000)	$ 5,251,000
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent		34.00%	34.00%	34.00%
Deferred Tax Asset, Increase (Decrease) from Remeasurement Due to Tax Rate Change		$ (20,564,000)
Adjustments to Additional Paid in Capital, Share-based Compensation and Exercise of Stock Options		406,000
Net Operating Loss Carryforward Limitation		764,000
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense		0	$ 0	$ 0
Deferred Tax Assets, Valuation Allowance, Increase (Decrease) from Remeasurement Due to Tax Rate Change		(20,531,000)
Employee Stock Option [Member]
Unrecognized Tax Benefits		406,000
Domestic Tax Authority [Member]
Operating Loss Carryforwards		159,600,000
Domestic Tax Authority [Member] | Research Tax Credit Carryforward [Member]
Tax Credit Carryforward, Amount		189,000
Domestic Tax Authority [Member] | Liquidmetal Golf, Inc [Member]
Operating Loss Carryforwards		$ 36,200,000
Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member] | Earliest Tax Year [Member]
Open Tax Year		2,013
Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member] | Latest Tax Year [Member]
Open Tax Year		2,017
State and Local Jurisdiction [Member] | California Franchise Tax Board [Member]
Operating Loss Carryforwards		$ 82,800,000
State and Local Jurisdiction [Member] | California Franchise Tax Board [Member] | Earliest Tax Year [Member]
Open Tax Year		2,012
State and Local Jurisdiction [Member] | California Franchise Tax Board [Member] | Latest Tax Year [Member]
Open Tax Year		2,017
State and Local Jurisdiction [Member] | California Franchise Tax Board [Member] | Research Tax Credit Carryforward [Member]
Tax Credit Carryforward, Amount		$ 243,000
Scenario, Forecast [Member]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%

Note 16 - Income Taxes - Signif

Note 16 - Income Taxes - Significant Components of Deferred Tax Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Loss carry forwards	$ 39,304	$ 57,097
Derivative valuations	521	685
NQSO	1,794	2,214
Tax Credits	382	433
Other	(54)	(99)
Total deferred tax asset	41,947	60,330
Valuation allowance	(41,947)	(60,330)
Total deferred tax asset, net

Note 16 - Income Taxes - Differ

Note 16 - Income Taxes - Differences Between the Expected Federal Tax Benefit and Actual Tax Provision (Details)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Expected federal tax benefit	(34.00%)	(34.00%)	(34.00%)
Permanent items	1.70%	5.60%	0.40%
Net operating loss utilized or expired	0.00%	0.00%	0.00%
Increase in valuation allowance and others	32.30%	28.40%	33.60%
Effective tax rate	0.00%	0.00%	0.00%

Note 17 - Loss Per Common Sha76

Note 17 - Loss Per Common Share (Details Textual) - $ / shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.17	$ 0.15	$ 0.21
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	34,434,994	47,582,402	41,910,734
Employee Stock Option [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.07	$ 0.07	$ 0.08
Employee Stock Option [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.47	$ 0.77	$ 1.44
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	10,066,809	41,924,653	36,509,931
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.07
Warrant [Member] | Minimum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.07	$ 0.17
Warrant [Member] | Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.17	$ 0.19

Note 18 - Segment Information (

Note 18 - Segment Information (Details Textual)	12 Months Ended
	Dec. 31, 2017
Number of Reportable Segments	1

Note 19 - Commitments and Con78

Note 19 - Commitments and Contingencies (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Operating Leases, Rent Expense, Net	$ 130	$ 225	$ 225
Depreciation	548	$ 429	$ 423
Operating Lease Termination [Member]
Lease Termination Fees Paid	125
Operating Leases, Rent Expense, Net	17
Operating Lease Termination [Member] | Leasehold Improvements [Member]
Depreciation	30
Alloy Purchase Commitments [Member]
Long-term Purchase Commitment, Amount	$ 308

Note 20 - 401(k) Savings Plan (

Note 20 - 401(k) Savings Plan (Details Textual)	12 Months Ended
	Dec. 31, 2017
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent	15.00%

Note 21 - Related Party Trans80

Note 21 - Related Party Transactions (Details Textual) - USD ($)	Aug. 16, 2017	Nov. 17, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Mar. 10, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number			32,763,190
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number			20,231,888
Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost			$ 261,000	$ 367,000	$ 13,000
The 2016 Purchase Agreement [Member]
Common Stock Purchase Agreement, Number of Shares Authorized to Issue and Sell to Investors						405,000,000
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors						$ 63,400,000
Mr. Steipp [Member] | The Separation Agreement [Member]
Severance Costs		$ 300,000
Separation Agreement, Period for COBRA Healthcare Coverage		1 year
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number		3,990,400
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number		10,777,949
Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost				297,000
Accrued Liabilities			0	301,000
Former CFO [Member] | Former CFO Separation Agreement [Member]
Separation Agreement, Period for COBRA Healthcare Coverage	1 year
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	247,650
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	2,889,749
Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost			89,000
Accrued Liabilities			$ 164,000	0
Separation Agreement, Base Annual Salary	$ 240,000
Separation Agreement, Period for Base Annual Salary	1 year
Chairman of Eontec [Member] | Minimum [Member]
Beneficial Ownership Percentage			5.00%
Eontec [Member] | License Agreement [Member]
Related Party Transaction, Amounts of Transaction			$ 877,000	$ 68,000	$ 0

Note 22 - Quarterly Financial81

Note 22 - Quarterly Financial Information (Unaudited) - Quarterly Financial Information (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Revenue	$ 179	$ 36	$ 58	$ 48	$ 124	$ 154	$ 34	$ 168	$ 321	$ 480	$ 125
Gross profit (loss)	(301)	(51)	(9)	(14)	(93)	(11)	21	10	(375)	(73)	(224)
Operating loss	(2,406)	(2,290)	(1,797)	(2,109)	(2,716)	(2,238)	(2,367)	(2,566)	(8,602)	(9,887)	(9,281)
Net loss and comprehensive loss	$ 27	$ (3,951)	$ (3,821)	$ (945)	$ (4,948)	$ (3,802)	$ (824)	$ (9,178)	$ (8,690)	$ (18,752)	$ (7,317)
Basic and diluted net loss per common share (in dollars per share)	$ 0	$ 0	$ 0	$ 0	$ 0	$ (0.01)	$ 0	$ (0.02)	$ (0.01)	$ (0.03)

Schedule II - Valuation and Q82

Schedule II - Valuation and Qualifying Accounts - Summary of Valuation and Qualifying Accounts (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Balance at beginning of period	$ 60,330	$ 55,079	$ 54,948
Charged to costs and expenses	2,834	6,675	4,470
Charged to other accounts	0	0	0
Deductions	(21,217)	(1,424)	(4,339)
Balance at end of period	41,947	60,330	55,079
Allowance for Doubtful Accounts [Member]
Balance at beginning of period
Charged to costs and expenses			19
Charged to other accounts
Deductions			(19)
Balance at end of period
Valuation Allowance of Deferred Tax Assets [Member]
Balance at beginning of period	60,330	55,079	54,948
Charged to costs and expenses	2,834	6,675	4,451
Charged to other accounts
Deductions	(21,217)	(1,424)	(4,320)
Balance at end of period	$ 41,947	$ 60,330	$ 55,079